Cargando…
Evaluation of MAGE-1 and MAGE-3 as tumour-specific markers to detect blood dissemination of hepatocellular carcinoma cells
The members of MAGE gene family are highly expressed in human hepatocellular carcinoma (HCC). In the present study, we tested the tumour-specific MAGE-1 and MAGE-3 transcripts in the peripheral blood of HCC patients by nested RT–PCR to detect the circulating tumour cells and evaluate their potential...
Autores principales: | Mou, D-C, Cai, S-L, Peng, J-R, Wang, Y, Chen, H-S, Pang, X-W, Leng, X-S, Chen, W-F |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2746529/ https://www.ncbi.nlm.nih.gov/pubmed/11857021 http://dx.doi.org/10.1038/sj.bjc.6600016 |
Ejemplares similares
-
Demethylation of MAGE promoters during gastric cancer progression
por: Honda, T, et al.
Publicado: (2004) -
MAGE-A protein and MAGE-A10 gene expressions in liver metastasis in patients with stomach cancer
por: Suzuki, S, et al.
Publicado: (2008) -
Identification of two novel CT antigens and their capacity to elicit antibody response in hepatocellular carcinoma patients
por: Dong, X-Y, et al.
Publicado: (2003) -
In vivo enhancement of the MAGE-specific cellular immune response by a recombinant MAGE1-MAGE3-TBHSP70 tumor vaccine
por: Junwei, Wang, et al.
Publicado: (2016) -
Erratum to: In vivo enhancement of the MAGE-specific cellular immune response by a recombinant MAGE1-MAGE3-TBHSP70 tumor vaccine
por: Junwei, Wang, et al.
Publicado: (2017)